Pharmaceuticals FDA Issues Draft Guidelines on Diversity of Clinical Trial Populations Last updated: June 27, 2024 11:57 am By bexib 0 Min Read Share SHARE This guidance is intended to assist sponsors in recruiting test populations that accurately represent real-world populations. You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article New eCommerce Tools: June 27, 2024 Next Article Fungicide Strategies for Quality and Yield – RealAgriculture Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News Remaking history: Sarah Mather and Aquascope Manufacturing Christmas has arrived at Orelle – Luxury Hospitality Magazine Hospitality & Tourism A look inside: Allies developing a multicloud hybrid strategy Banking 2024 Holiday Shipping Deadline for the United States International Shipping